This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Uterine Cancer
and you are
between 20 and 70
years old
The phase for this study is not defined.
Show me locations

The purpose

Surgical stress and anesthesia may cause immunosuppression in immunocompromised cancer patients. The natural killer (NK) cell is a critical part of anti-tumor immunity. Dexmedetomidine has sympatholytic effect and preserves NK cell function. This study investigate the effect of dexmedetomidine on immune suppression and postoperative outcomes in patients undergoing uterine cancer resection.

Provided treatments

  • Drug: Dexmedetomidine group
  • Drug: Control group

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02896413. The sponsor of the trial is Yonsei University and it is looking for 100 volunteers for the current phase.
Official trial title: